Through LF Investment ApS (LFI) is Lauritzen Fonden engaged in the following companies:
Frederikshavn Maritime Business Erhvervspark A/S runs the real estate leasing at Danyards former shipyard areas in Aalborg and Frederikshavn. FME dispose over 50.000 kvm office, production and storage space. They are currently leased to more than 70 different tenants. Read more about FME.
Biotech company that reseaches in a groundbreaking cancer treatment drug called BP-C1. The has tested more effective than other cancer treatments such as chemo therapy and has almost no side effects. Read more about Meabco.
Production of sustainable building blocks for the construction of all types of internal and external walls. The blocks are made of 80 pct. reusable material and only 20 pct. cement. In addition the blocks are sound absorbent. Read more about Durisol.
Invest Brasil A/S
Founded in 2008. Investments in real estate projects, business properties and shopping centres for the rapidly growing Brazilian middle class. Read more here.
Smartvan provides professional equipment for vansSmart. Read more about SmartVan.
NanoNord develops real-time analytical equipment to various industries using NMR technologies. The company has developed CatGuard which measures catfines (catalytic fines) in ships bunker oil and Tveskaeg which measures critical impurity in water or in the waste water industry. Read more about NanoNord.
Axis Offshore Pte. Ltd.
The main activity of Axis Offshore is to operate the Safe Swift, a high-end monohull accomodation vessel for oilrigs and other industries at sea.
Expanite has developed a fast and cost-effective process for superior surface hardening of stainless steel. Products treated with Expanite technology significantly improves corrosion, galling, fatigue and wear-resistance according to the customers particular needs. Read more about Expanite.
Biotech company developing a vaccine against the infection called group B streptococcus. Especially aimed at protecting pregnant women from passing on harmful viruses to their newborns. Read more about MinervaX.